Ohio · 0003M

Molecular Pathology Test For Liver Disease, Including Non-Alcohol Liver Disease (nash Fibrosure) in Ohio

Ohio Medicare Avg
$394.67
16% below national avg
National Medicare Avg
$472.42
All states combined
Billed Charge (OH)
$2,013.60
What providers submit
Est. Commercial (OH)
$1,040.24
National avg: $1,085.69
Est. Cash / Self-Pay (OH)
$925.25
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

18
Services in OH
1
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Ohio

Provider Medicare Services
Compunet Clinical Laboratories Llc $394.67 18

Ohio Pricing in Context

In Ohio, CPT code 0003M (Molecular Pathology Test For Liver Disease, Including Non-Alcohol Liver Disease (nash Fibrosure)) carries an average Medicare payment of $394.67 — 16% below the national benchmark of $472.42. 1 providers across the state submitted claims for this procedure in 2023, performing 18 total services. Individual payments in OH ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Ohio is $2,013.60, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Ohio sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Other procedures, the estimated commercial insurance price in Ohio lands near $1,040.24, with self-pay cash prices typically around $925.25. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Molecular Pathology Test For Liver Disease, Including Non-Alcohol Liver Disease (nash Fibrosure) cost in Ohio?

The average Medicare payment for Molecular Pathology Test For Liver Disease, Including Non-Alcohol Liver Disease (nash Fibrosure) in Ohio is $394.67, which is 16% below the national average of $472.42. Providers in OH typically bill $2,013.60 for this procedure.

What does Molecular Pathology Test For Liver Disease, Including Non-Alcohol Liver Disease (nash Fibrosure) cost with insurance in Ohio?

With commercial insurance in Ohio, Molecular Pathology Test For Liver Disease, Including Non-Alcohol Liver Disease (nash Fibrosure) costs an estimated $1,040.24. Without insurance, the estimated cash price is $925.25. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Molecular Pathology Test For Liver Disease, Including Non-Alcohol Liver Disease (nash Fibrosure) in Ohio?

1 providers in Ohio billed Medicare for Molecular Pathology Test For Liver Disease, Including Non-Alcohol Liver Disease (nash Fibrosure) in 2023, performing 18 total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Molecular Pathology Test For Liver Disease, Including Non-Alcohol Liver Disease (nash Fibrosure) cheaper in Ohio than the national average?

Yes — Molecular Pathology Test For Liver Disease, Including Non-Alcohol Liver Disease (nash Fibrosure) costs 16% below the national average in Ohio. The state average Medicare payment is $394.67 compared to $472.42 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial